Asia-Pacific Blood Transfusion Diagnostics Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028

Analysis By Product (Instruments & Kits and Reagents), Application (Blood Grouping and Disease Screening), and End User (Hospitals, Diagnostic Laboratories, Blood Banks, and Plasma Fractionation Companies)

No. of Pages: 140
Report Code: BMIRE00027402
Category: Life Sciences
Asia-Pacific Blood Transfusion Diagnostics Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Asia-Pacific Blood Transfusion Diagnostics Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Asia-Pacific Blood Transfusion Diagnostics Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Asia-Pacific Blood Transfusion Diagnostics Market Regional Analysis

6.2 Asia-Pacific Blood Transfusion Diagnostics Market Revenue 2020-2028 (US$ Million)
6.3 Asia-Pacific Blood Transfusion Diagnostics Market Forecast Analysis

7. Asia-Pacific Blood Transfusion Diagnostics Market Analysis – by Product

7.1 Instruments & Kits
  • 7.1.1 Overview
  • 7.1.2 Instruments & Kits: Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 Reagents
  • 7.2.1 Overview
  • 7.2.2 Reagents: Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. Asia-Pacific Blood Transfusion Diagnostics Market Analysis – by Application

8.1 Blood Grouping
  • 8.1.1 Overview
  • 8.1.2 Blood Grouping: Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.2 Disease Screening
  • 8.2.1 Overview
  • 8.2.2 Disease Screening: Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. Asia-Pacific Blood Transfusion Diagnostics Market Analysis – by End User

9.1 Hospitals
  • 9.1.1 Overview
  • 9.1.2 Hospitals: Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.2 Diagnostic Laboratories
  • 9.2.1 Overview
  • 9.2.2 Diagnostic Laboratories: Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.3 Blood Banks
  • 9.3.1 Overview
  • 9.3.2 Blood Banks: Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.4 Plasma Fractionation Companies
  • 9.4.1 Overview
  • 9.4.2 Plasma Fractionation Companies : Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. Asia-Pacific Blood Transfusion Diagnostics Market – Asia-Pacific Analysis

10.1 Overview

10.2 Asia-Pacific
  • 10.2.1 Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.2.1.1 Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 China: Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.1.1 China: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by Product
    • 10.2.1.1.2 China: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by Application
    • 10.2.1.1.3 China: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by End User
  • 10.2.1.2 India: Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.2.1 India: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by Product
    • 10.2.1.2.2 India: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by Application
    • 10.2.1.2.3 India: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by End User
  • 10.2.1.3 Japan: Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.3.1 Japan: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by Product
    • 10.2.1.3.2 Japan: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by Application
    • 10.2.1.3.3 Japan: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by End User
  • 10.2.1.4 Australia: Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.4.1 Australia: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by Product
    • 10.2.1.4.2 Australia: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by Application
    • 10.2.1.4.3 Australia: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by End User
  • 10.2.1.5 Rest of Asia-Pacific : Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.5.1 Rest of Asia-Pacific : Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by Product
    • 10.2.1.5.2 Rest of Asia-Pacific : Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by Application
    • 10.2.1.5.3 Rest of Asia-Pacific : Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 Abbott
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 BAG Diagnostics GmbH
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Bio-Rad Laboratories, Inc.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 DiaSorin S.p.A.
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 F. Hoffmann-La Roche Ltd
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Grifols, S.A.
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Immucor, Inc.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Ortho Clinical Diagnostics (QuidelOrtho Corporation)
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Quotient Limited
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Thermo Fisher Scientific Inc.
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - Asia-Pacific Blood Transfusion Diagnostics Market

  • Abbott
  • BAG Diagnostics GmbH
  • Bio-Rad Laboratories, Inc.
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd
  • Grifols, S.A.
  • Immucor, Inc.
  • Ortho Clinical Diagnostics (QuidelOrtho Corporation)
  • Quotient Limited
  • Thermo Fisher Scientific Inc.
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)